Treatment of high-risk solid tumors of childhood with myeloablative chemotherapy and autologous stem cell transplantation: A single institution experience

Oncology Reports

Volumn 3, Issue 3, 1996, Pages 519-525

  Yokoyama, Jotaro ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Autologous bone marrow transplantation (ABMT); Myeloblative chemotherapy; Peripheral blood stem cell transplantation (PBSCT); Solid tumor of childhood

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; DACARBAZINE; DACTINOMYCIN; DIMETHOATE; ETOPOSIDE; IDARUBICIN; MELPHALAN; PIRARUBICIN; VINCRISTINE;

ADOLESCENT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SOLID TUMOR; STEM CELL TRANSPLANTATION;

EID: 0029935685     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Seeger RC and Reynolds CP: Treatment of high-risk solid tumors of childhood with intensive therapy and autologous bone marrow transplantation. Pediatr Clin North Am 38: 393-424, 1991.
2. Lacone A, Pierelli L, Quaglietta AM, et al: Survival after PBSC transplantation and comparison of engraftment speed with autologous and allogenic marrow transplantation: results of a multicenter study. Int J Artif Organs 16 (Suppl 5): 45-50, 1993.